Ignite Creation Date:
2025-12-25 @ 1:28 AM
Ignite Modification Date:
2025-12-26 @ 4:42 PM
Study NCT ID:
NCT07223294
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-12-12
First Post:
2025-10-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate the Therapeutic Equivalence and Safety of Fluticasone Furoate and Vilanterol Inhalation Powder 100 mcg/25 mcg and BREO ELLIPTA 100 mcg/25 mcg in Participants With Asthma
Sponsor:
Sandoz
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-10-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-10-31
Completion Date Type:
ESTIMATED
First Submit Date:
2025-10-15
First Submit QC Date:
None
Study First Post Date:
2025-10-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-11
Last Update Post Date:
2025-12-12
Last Update Post Date Type:
ESTIMATED